The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 6.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are up 4%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (16 analysts) rates it buy, with a mean price target of $1251.
BlackRock
BLK · a US exchange · USD · Market cap $178.0B · 25,400 employees
BlackRock, Inc.
FAIL · Does not pass the screenAt the last full screen
2026-09-08
Screened 2026-09-08 · the tape above runs as of 09:00 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
This name holds its markdown label.
BlackRock holds its Markdown at $1,095.37. The statistical read favours the buyers, held for 40 days.
| Phase | Markdown · caution |
| Quantitative state | The statistical read favours the buyers, held for 40 days |
| Price at the screen | $1,095.37 |
| Valuation | 26.24 trailing · 17.04 forward price to earnings |
| Values screen | FAIL · score 10.0 |
| Beta | 1.43 |
Five Screens, Shown in Full
Does not pass. Business activity screen
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Excluded | Core business clean | Business activity: Financials sector | Fail |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is WorthThe Fair Value Range
Our framework reads AVOID: it trades at roughly a 4% discount to our $1,137.13 fair value, 30.60% revenue growth.
Fair value range in USD, drawn from the 2026-09-08 screen. The gold marker is the market price at the same screen. A 3.8% margin of safety to the base estimate.
Third-party analyst targets: 16 covering, consensus None. The average target sits +20% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-08 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsAn Asset Giant Struggling with Ethics
Imagine a world where every dollar in investment has a ripple effect, shaping economies and lives - this is BlackRock's domain. As the world's largest asset manager, BlackRock orchestrates trillions, influencing global finance through its vast portfolio. Yet, despite its market sway, the firm falls short on ethical grounds, failing our ethical screen due to certain questionable business activities.
Why it stands out - on paper. With a robust revenue growth of 31%, a healthy profit margin of 24%, and a ROE of 12%, BlackRock's financial metrics would typically make it an attractive proposition for investors seeking both growth and stability. Its forward P/E of 17.8x aligns closely with our fair valuation, suggesting the market's current pricing is neither over nor underestimating its potential.
However, despite the attractive financials, we must pass on BlackRock. The firm's failure on our ethical screen is a significant red flag for an industry that holds so much power over societal wellbeing. While the consensus rating from analysts is a 'buy' with a median target suggesting a potential upside, the ethical considerations cannot be overlooked. This is a stark reminder that financial performance and ethical standards do not always go hand in hand. Analysis, not advice.
| Forward P/E | 17.0xcheap for a company growing this fast |
| Trailing P/E | 26.2xa premium valuation |
| EPS, trailing | 41.75 |
| EPS, forward | 64.28 |
| Revenue growth | +30.6%strong top-line growth |
| Profit margin | 24.1%healthy profit margins |
| Return on equity | 12.3%a solid return on shareholder capital |
| FCF yield | 4.26% |
| Dividend yield | 211.00% |
| Debt to equity | 0.23minimal debt: a conservative balance sheet |
| Current ratio | 2.45comfortably covers its short-term bills |
| Beta | 1.43moves a little more than the market |
| Short interest, float | 0.01% |
| 52-week range | 917.39 - 1,219.94 |
| Market cap | $178.0B |
| Employees | 25,400 |
The risks · The things to watch: it already moves more than the market on an average day.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeBLK trades on a US exchange. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 7.7% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are up 4%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (16 analysts) rates it buy, with a mean price target of $1251.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are up 4%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (16 analysts) rates it buy, with a mean price target of $1251.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- SCHD’s International Twin Has Rivals From Vanguard, Fidelity, and BlackRock. We Ranked All Four 24/7 Wall St. · 13h ago
- ETF League Tables: Capital Group Nears $160B In AUM etf.com · 14h ago
- Nvidia Expects Chip Sales to Double in 2027 24/7 Wall St. · 19h ago
- BlackRock’s Rick Rieder Turns Cautious on US Stocks, Warns $40 Trillion Debt Is Becoming a ‘Compounding…Problem’ (CORRECTED) Benzinga · 20h ago
- Democrat Sweep Odds Just Hit a Record 60%. History Says This Is Exactly When Midterm-Year Stock Drawdowns Happen. 24/7 Wall St. · 20h ago
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-28 | FINK LAURENCE D | Chief Executive Officer | 33,900 | $35,613,717 | |
| 2026-04-27 | KAPITO ROBERT S | President | 8,739 | $9,233,596 | |
| 2026-03-31 | FREDA FABRIZIO | Director | 21 | · | |
| 2026-03-31 | ROBBINS CHARLES H | Director | 30 | · | |
| 2026-03-31 | PECK KRISTIN C | Director | 34 | · | |
| 2026-03-31 | DALEY PAMELA | Director | 40 | · | |
| 2026-03-31 | JOHNSON MARGARET L | Director | 37 | · | |
| 2026-03-31 | FORD WILLIAM E | Director | 38 | · | |
| 2026-03-31 | VESTBERG HANS ERIK | Director | 36 | · | |
| 2026-03-31 | NIXON, GORDON MELBOURNE | Director | 38 | · |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 7 Jul2026 | Ro Khanna | Democrat | sell | 15K–50K |
| 7 Jul2026 | Ro Khanna | Democrat | sell | 15K–50K |
| 7 Jul2026 | Ro Khanna | Democrat | sell | 15K–50K |
| 30 Jul2026 | Rich McCormick | Republican | sell | 1K–15K |
| 30 Jul2026 | Rich McCormick | Republican | sell | 1K–15K |
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $1,075.26 | -6.2% | $5.73 | $943 | -5.7% |
| 2 months | $993.71 | +1.5% | $5.73 | $1,021 | +2.1% |
| 3 months | $917.73 | +9.9% | $5.73 | $1,105 | +10.5% |
| 6 months | $1,089.60 | -7.4% | $11.46 | $936 | -6.4% |
| 1 year | $971.54 | +3.8% | $21.88 | $1,061 | +6.1% |
| 2 years | $734.43 | +37.4% | $42.50 | $1,431 | +43.1% |
| 3 years | $638.81 | +57.9% | $62.70 | $1,677 | +67.7% |
| 5 years | $780.66 | +29.2% | $100.48 | $1,421 | +42.1% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever BLK does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.